Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Outcome analysis of 71 clinical intestinal transplantations

Todo, S and Reyes, J and Furukawa, H and Abu-Elmagd, K and Lee, RG and Tzakis, A and Rao, AS and Starzl, TE (1995) Outcome analysis of 71 clinical intestinal transplantations. Annals of Surgery, 222 (3). 270 - 282. ISSN 0003-4932

Accepted Version
Available under License : See the attached license file.

Download (2MB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)


Objective: The aim of the study was to determine risk factors associated with graft failure and mortality after transplantation of the intestine alone or as pad of an organ complex. Summary Background Data: Even with modern immunosuppressive therapies, clinical intestinal transplantation remains a difficult and unreliable procedure. Causes for this and solutions are needed. Methods: Between May 1990 and February 1995, 71 intestinal transplantations were performed in 66 patients using tacrolimus and low-dose steroids. The first 63 patients, all but one treated 1 to 5 years ago, received either isolated grafts (n = 22), liver and intestinal grafts (n = 30), or multivisceral grafts (n = 11). Three mere recipients of allografts who recently underwent surgery and one undergoing retransplantation were given unaltered donor bone marrow cells perioperatively as a biologic adjuvant. Results: Of the first 63 recipients, 32 are alive: 28 have functioning primary grafts and 4 have resumed total parenteral nutrition after graft enterectomy. Thirty-five primary grafts were lost to technical and management errors (n = 10), rejection (n = 6), and infection (n = 19). Regression analysis revealed that duration of surgery, positive donor cytomegalovirus (CMV) serology, inclusion of graft colon, OKT3 use, steroid recycle, and high tacrolimus blood levels contributed to graft loss. All four intestine and bone marrow recipients are alive for 2-3 months without evidence of graft- versus-host disease. Conclusion: To improve outcome after intestinal transplantation with previous management protocols, it will be necessary to avoid predictably difficult patients, CMV seropositive donors, and inclusion of the graft colon. Bone marrow transplantation may further improve outcome by ameliorating the biologic barriers of rejection and infection and allowing less restrictive selection criteria.


Social Networking:
Share |


Item Type: Article
Status: Published
CreatorsEmailPitt UsernameORCID
Todo, S
Reyes, J
Furukawa, H
Abu-Elmagd, K
Lee, RG
Tzakis, A
Rao, AS
Starzl, TEtes11@pitt.eduTES11
Centers: Other Centers, Institutes, Offices, or Units > Thomas E. Starzl Transplantation Institute
Date: 1 January 1995
Date Type: Publication
Journal or Publication Title: Annals of Surgery
Volume: 222
Number: 3
Page Range: 270 - 282
DOI or Unique Handle: 10.1097/00000658-199509000-00006
Institution: University of Pittsburgh
Refereed: Yes
ISSN: 0003-4932
Other ID: uls-drl:31735062126739, Starzl CV No. 1800
Date Deposited: 08 Apr 2010 17:30
Last Modified: 02 Feb 2019 13:55


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item